Clinical trial
A Multicenter, Randomized Trial Comparing The Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Subjects With Hematological Malignancy
NCT02895529 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized Trial Comparing The Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Subjects With Hematological Malignancy
- Lead sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2016
- Completion date
- May 2, 2018
- Enrollment
- 61 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.